Ra Capital Management, L.P. Achilles Therapeutics PLC Transaction History

Ra Capital Management, L.P.

  • $7.17 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
SELL
$0.79 - $2.39 $2.69 Million - $8.14 Million
-3,406,853 Reduced 67.94%
1,607,834 $1.45 Million
Q2 2021

Aug 16, 2021
BUY
$9.79 - $17.86 $35.5 Million - $64.8 Million
3,625,799 Added 261.06%
5,014,687 $49.1 Million
Q1 2021

May 17, 2021
BUY
$16.55 - $16.55 $23 Million - $23 Million
1,388,888 New
1,388,888 $23 Million

Others Institutions Holding ACHL

# of Institutions
24
Shares Held
24.3M
Call Options Held
0
Put Options Held
0
View Full List

About Achilles Therapeutics plc

ACHL Quotes by TradingView
  • Ticker ACHL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,774,000
  • Market Cap $42M
  • Description
  • Achilles Therapeutics Plc, a clinical stage immuno-oncology biopharmaceutical company, develops precision T cell therapies to treat various solid tumors. The company's lead product candidates include CHIRON, which is in Phase I/IIa clinical trial for use in the treatment of advanced non-small cell lung cancer; and THETIS, a product candidate in ...
More about ACHL
Track This Portfolio

Track Ra Capital Management, L.P. Portfolio

Follow Ra Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ra Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Ra Capital Management, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email